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Cas isamultidomainsignalingprotein that resides in focal adhe-
sions.Caspossesses a large central substratedomain containing15
repeats of the sequence YXXP, which are phosphorylated by Src.
The phosphorylation sites are essential for the roles of Cas in cell
migration and in regulation of the actin cytoskeleton.We showed
previously that Src catalyzes the multisite phosphorylation of Cas
viaaprocessivemechanism. In this study,wecreatedmutant forms
ofCas to identify thedeterminants forprocessivephosphorylation.
Mutants containing singleormultipleYXXPmutationswerephos-
phorylated processively by Src, suggesting that individual sites are
dispensable. The results also suggest that there is no defined order
to the Cas phosphorylation events. We also studied the effects of
these mutations by reintroducing Cas into Cas-deficient fibro-
blasts.Mutants lacking some or all YXXP sites augment the ability
of Src to promote anchorage-independent growth. On the other
hand,deletionofYXXPsites compromises theabilityofCas topro-
mote tumor cell migration.
p130cas (Crk-associated substrate, 130 kDa) was originally
identified as a focal adhesion protein that is highly tyrosine-
phosphorylated during transformation by v-Src and v-Crk and
that also forms stable complexeswith these oncoproteins (1–3).
Activated Src does not induce a complete transformed pheno-
type when expressed in Cas-deficient fibroblasts, indicating a
role for Cas in cellular transformation by Src (4). Recent studies
have revealedmultiple signaling roles for Cas in normal cells (5,
6). Mouse embryos lacking Cas die in utero because of the
defects in cardiovascular development, disorganization ofmyo-
fibrils, impaired actin stress fiber association, and growth retar-
dation (4). Cas-deficient fibroblasts contain short, disorganized
actin filaments, and actin stress fiber organization is restored
after ectopic expression of Cas (4, 7). These results suggest a
crucial role for Cas in the regulation of the actin cytoskeleton.
Cas possesses an N-terminal SH32 domain, a large central
substrate domain containing 15 repeats of themotif YXXP, and
a C-terminal Src binding region (Fig. 1A). The YXXPmotifs are
substrates for several tyrosine kinases and serve as binding sites
for the adapter protein Crk and other SH2 domain-containing
signaling proteins (5, 6). The YXXPmotifs of Cas can be divided
into YDXP and YQXP motifs (Fig. 1B). The YDXP motifs are
important for actin cytoskeleton organization and cell migra-
tion (8). We and others have mapped the sites of Src phospho-
rylation within the Cas substrate domain (9, 10). These phos-
phorylation sites play an important role in Cas-associated
functions such as cell migration and regulation of the actin
cytoskeleton.
Multisite phosphorylation can be carried out by two basic
mechanisms: (i) a processive mechanism in which the enzyme
binds to the substrate and catalyzes all the phosphorylation
events before dissociating from the fully phosphorylated prod-
uct; or (ii) a distributive mechanism in which each phosphoryl-
ation is the result of a separate enzyme-substrate binding event.
The dual phosphorylation ofmitogen-activated protein kinases
by mitogen-activated protein kinases takes place in a two-
collision, distributive manner (11, 12). In contrast, recent
kinetic studies on the spliceosomal SR proteins show that they
are phosphorylated processively by SR protein-specific Ser/Thr
kinases (13). We showed previously that Src phosphorylates
Cas by a processivemechanism in which Src binds to the C-ter-
minal polyproline region of Cas and catalyzes the multiple
phosphorylation events (14).
In many systems, the biological effects of multisite phospho-
rylation are distinguishable from those of single-site phospho-
rylation. For example, multisite phosphorylation of the cyclin-
dependent kinase inhibitor Sic1 is important in setting a
threshold for the onset of DNA synthesis (15). The biological
significance of processive phosphorylation of the YXXP motifs
in Cas remains unclear. Cas mutants lacking the entire sub-
strate domain or the YDXP motifs are defective in cell migra-
tion (8, 16). In cells transformed by oncogenic Src, the YXXP
motifs are important for invasiveness and formation of podo-
some structures (17, 18). Shin et al. (10) demonstrated that Cas
variants containing single or double tyrosine mutations pro-
mote cell migration at levels comparable with wild-type Cas,
whereas mutants containing as few as 6 tyrosines retain some
activity. Previous work from our laboratory highlighted the
importance of a particular tyrosine in the substrate domain
(Tyr253) in migration of Src-transformed cells (9). It was not
clear, however, whether this single site would be sufficient for
migration.
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In this study, we carried outmutational experiments to iden-
tify the determinants for processive phosphorylation of Cas by
Src. We also studied the effects of these mutations on cell
migration and anchorage-independent growth in Src-trans-
formed cells. Results from these studies suggest that no single
YXXP site is essential to subsequent phosphorylation of other
sites. Mutant forms of Cas lacking multiple sites are also phos-
phorylated processively by Src. In addition, we show that Cas
augments the ability of Src to promote anchorage-independent
growth, regardless of whether Cas is phosphorylated. In con-
trast to nonanchored growth, Cas must be phosphorylated on
at least 6 tyrosine residues by Src to promote tumor cell
migration.
MATERIALS AND METHODS
Antibodies—Anti-Cas monoclonal antibody was obtained
from BD Transduction Laboratories. Monoclonal antibody
against avian pp60v-Src kinase was obtained fromUpstate Bio-
technology, and anti--actin monoclonal antibody was
obtained from Santa Cruz Biotechnology.
Mutagenesis of Cas—Cas mutants were produced with the
QuikChange site-directedmutagenesis kit (Stratagene) accord-
ing to the manufacturer’s protocol. A baculovirus transfer vec-
tor encoding wild-type Cas (14) was used as a template. Muta-
genic primers contained 25–45 nucleotides, and the annealing
temperature was 55 °C. Multisite mutants were obtained by
mutagenizing 1 tyrosine at a time in the template. Tyrosine to
phenylalanine mutations were verified by DNA sequencing on
anABI 373 automatedDNAsequencer. The following tyrosines
were mutated to phenylalanine3,: for CasF7, Tyr119, Tyr196,
Tyr253, Tyr291, Tyr310, Tyr366, and Tyr414; for CasF12, the 7
tyrosines of CasF7 plus Tyr132, Tyr169, Tyr183, Tyr657, and
Tyr668; and for CasF17, the 12 tyrosines of CasF12 plus Tyr238,
Tyr271, Tyr331, Tyr376, and Tyr391.
Cas and Src Production in Sf9 Cells—N-terminal polyhisti-
dine-tagged v-Src andCaswere expressed using the Bac-to-Bac
baculovirus expression system (Invitrogen) as described (14).
3 CasF7, CasF12, and CasF17 refer to mutants lacking 7, 12, and 17 Tyr residues,
respectively.
FIGURE 1. Schematic representation of wild-type and mutant Cas proteins. A, domain structure of Cas showing the SH3 domain (SH3), proline-rich region
(Pro), substrate region containing 15 repeats of YXXP, serine-rich region (Ser), C-terminal Src binding sequence (SBS), and helix-loop-helix region (HLH). B,
diagram showing WT Cas and mutant forms of Cas used in this study with YDXP and YQXP motifs indicated above the diagram. In mutants CasF7, CasF12, and
CasF17, 7, 12, and 17 tyrosine residues were mutated to Phe, respectively. Tyrosine residues in the substrate domain are numbered and shown in black, and
mutated Tyr residues are shown in gray.
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Sf9 cells were grown at 27 °C in Excel 401 (JRH Biosciences) in
the presence of 2.5% heat-inactivated fetal bovine serum
(Sigma) and 1% penicillin/streptomycin/amphotericin B
(Invitrogen). Approximately 500–600ml of cells at a density of
1.5  106 cells/ml were infected with recombinant baculovirus
at a multiplicity of infection of 5–10 plaque-forming units/cell
for a period of 72 h. The cells were centrifuged and stored at
70 °C until needed. Wild-type and mutant forms of Cas were
purified using nickel-nitrilotriacetic acid resin (Qiagen) as
described previously (14). All purified proteins were stored at
20 °C.
In Vitro Kinase Assays—For experiments in which the total
phosphorylation of Cas was monitored, Cas was incubated in
the presence of 50 nM v-Src at 30 °C in kinase assay buffer (150
mM Tris-HCl, pH 7.5, 100 mM MgCl2, 5 mg/ml bovine serum
albumin). Reactions were started by the addition of 0.1 mM
unlabeled ATP plus [-32P]ATP (5 Ci), and aliquots were
withdrawn at various time points. The reactions were stopped
by mixing with Laemmli buffer and boiling and were analyzed
by SDS-PAGE followed by autoradiography. To quantitate
[-32P]ATP incorporation, the gels were dried and exposed to a
PhosphorImager screen (GE Healthcare), and the band inten-
sity was quantitated using ImageQuant software.
For pulse-chase assays in which the concentration of v-Src
was varied, 2MCas (wild-type ormutants) was incubatedwith
800 nM v-Src in kinase assay buffer in the presence of 0.1 M
[-32P]ATP for 3 min on ice. To analyze the pulse reaction,
an aliquot was removed and stopped by adding Laemmli
buffer and boiling. Additional aliquots of the reaction were
removed and diluted into four separate tubes containing
kinase buffer and 0.5 mM unlabeled ATP to give final enzyme
concentrations of 100, 200, 400, and 600 nM. These chase
reactions were carried out at 30 °C for an additional 25 min.
The reactions were stopped by adding Laemmli buffer and
boiling. Equal amounts of Cas from each reaction were ana-
lyzed by 8% SDS-PAGE and autoradiography.
To determine the stoichiometry of 32P incorporation, 1 M
Cas (wild-type or mutant) was incubated with 200 nM v-Src in
kinase assay buffer at 30 °C. Reactions were started by the addi-
tion of 0.1 mM unlabeled ATP plus [-32P]ATP (5 Ci), and
aliquots were withdrawn at various time points. The reactions
were stopped by mixing with Laemmli buffer and boiling and
analyzed by SDS-PAGE followed by staining with Coomassie
Blue. Bands were excised from the gel and dissolved in H2O2,
and 32P incorporation was measured using a liquid scintillation
counter.
Stable Expression of Cas and Src in Mammalian Cells—The
BamHI/NotI fragments encodingWT Cas or mutant Cas were
excised from pFastBac HTb and subcloned into the BamHI/
SnaBI sites of pBABEhygro (19). v-Src was expressed using the
vector pBABEpuro (9). Fibroblasts from homozygous null Cas
knock-out cells were used as described previously (4, 8). Cas
knock-out cells were transfected with equal concentrations of
both plasmids (1 g/well, 6-well plate). For controls, cells were
transfected with empty vectors (pBABEhygro and/or pBABE-
puro) as appropriate, and all the transfectants were selected for
hygromycin resistance and puromycin resistance conferred by
the transfection vectors. Clones were not taken from the result-
ant stable cells to avoid the potential consequences of clonal
variation.
Western Blot Analysis of Mammalian Cells—Western blot
analysis was performed on Cas-deficient cells grown for 72 h
after plating. Briefly, cells were quickly aspirated, washed with
phosphate-buffered saline, and lysed inmodified radioimmune
precipitation assay buffer (50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 5mM EDTA, 1%Nonidet P-40, 1% sodium deoxycholate,
5 mg/liter aprotinin, 5 mg/liter leupeptin, 0.1 mM phenylmeth-
ylsufonyl fluoride, 1 mM Na3VO4) at 4 °C for 45 min. The cell
lysateswere centrifuged at 14,000 g for 10min at 4 °C. Protein
concentrations were determined using Bio-Rad protein assay.
Lysates (30 g) were separated on 8% SDS-PAGE and trans-
ferred onto polyvinylidene difluoride membrane. Membranes
were incubated with anti-Cas primary antibody overnight fol-
lowed by incubation with horseradish peroxidase-conjugated
secondary antibody and detected by ECL plus (Amersham
Biosciences).
Cell Growth Assays—Cas-deficient fibroblasts were analyzed
bymethods described previously (9, 20, 21). Cellswere grown in
Dulbecco’s modified Eagle’s medium plus 10% fetal bovine
serum at 37 °C in 100% humidity. All comparisons were done in
parallel to avoid any changes in culture conditions between
experiments. To examine anchored growth, 20,000 cells were
seeded at 1 ml/well in tissue culture-treated 12-well cluster
plates (Falcon). To measure nonanchored growth, 20,000 cells
were seeded in ultra low attachment 24-well cluster plates
(Corning). Cell numbers were obtained by Coulter counter.
To measure cell migration, 200,000 cells were plated in
6-well cluster plates on cell culture inserts with a 3- or 8-m
pore size (Transwell-Clear, Costar) and grown for 72 or 24 h,
respectively. Cells were then released separately from the top of
the membrane, the bottom of the membrane, and the well
beneath the membrane. Migration was then quantitated as the
percent of cells found in the well over the total cell number.
RESULTS
Single-site Mutants of Cas Are Phosphorylated by Src—We
first tested whether selected substrate motifs in Cas play a crit-
ical role in directing Src phosphorylation. Based on our previ-
ous synthetic peptide studies, we selected 4 tyrosine residues in
the substrate domain of Cas for analysis: Tyr253, Tyr310, Tyr366,
and Tyr414. Synthetic peptide substrates modeled on these four
sites showed the highest values of kcat/Km for Src phosphoryla-
tion of the peptides tested (9). We expressed and purified wild-
type Cas as well as Cas mutants containing Tyr to Phe substi-
tutions at these four sites. To study the effect of these single-
site mutations on Cas phosphorylation by Src, we carried out
in vitro kinase assays using purified v-Src and [-32P]ATP.
The phosphorylation rates of WT Cas and the single-site
mutants were comparable as determined by densitometry
(Fig. 2). These results show that of the residues tested, no
single site is crucial for in vitro phosphorylation of Cas by
Src.
Src Phosphorylates Multisite Mutants of Cas in a Processive
Manner—We generated three multisite mutants of Cas with
multiple tyrosine to phenylalanine substitutions: CasF7, CasF12,
and CasF17 (Fig. 1B). In CasF7, we mutated 7 tyrosine residues
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that were phosphorylated efficiently by Src in the context of
synthetic peptides (9). In CasF12, we mutated 7 tyrosines of
CasF7, an additional 3 tyrosine residues in the substrate domain
of Cas that weremapped bymass spectrometry (9), and the two
potential tyrosine phosphorylation sites in the C terminus of
Cas. In CasF17, we mutated 12 tyrosines of CasF12 plus an addi-
tional 5 tyrosines in the substrate domain of Cas. Thus, in
CasF17, all the YXXP tyrosines of the substrate domain were
eliminated.
We carried out in vitro kinase reactions with purified Src and
Cas proteins. We removed aliquots of the reactions at different
time points and analyzed them by SDS-PAGE and silver stain-
ing. As we reported previously (14), multisite phosphorylation
of wild-type Cas produces a large shift in its electrophoretic
mobility (Fig. 3). The single discrete band is consistent with a
processive mechanism because no partially phosphorylated
forms are observed. Src phosphorylation of the multisite
mutants CasF7 and CasF12 also produced a shift in electro-
phoretic mobility (Fig. 3). The shift was not as large as for WT
Cas, presumably because of the lower number of phosphoryla-
tion sites present in these mutants. The shifted bands for CasF7
and CasF12 remained sharp. We did not observe significant
phosphorylation of CasF17 in this experiment (Fig. 3A) or in
experiments with [-32P]ATP (data not shown).
We analyzed the overall phosphorylation rates of WT Cas,
CasF7, and CasF12 by in vitro kinase assays using [-32P]ATP. A
characteristic of processive phosphorylation is that the produc-
tion of fully phosphorylated product follows classical Michae-
lian kinetics. In contrast, for a nonprocessive mechanism,
increasing the concentration of substrate results in decreased
accumulation of fully phosphorylated product (11, 12). This
characteristic of nonprocessive reactions is because of the com-
petition between unphosphorylated substrate and partially
phosphorylated substrates each time the substrate and enzyme
dissociate. We carried out the reactions at five different con-
centrations of Cas (0.1, 0.5, 1, 2.5, and 4 M). We removed
aliquots of the reaction at different time points and analyzed
them by SDS-PAGE and autoradiography. To quantitate 32P
incorporation, the gels were dried and exposed to a Phos-
FIGURE 2. Single-site mutants of Cas are phosphorylated by Src. In vitro
kinase assays were carried out at 30 °C using purified Cas proteins (WT or
mutant), purified v-Src, and [-32P]ATP. Aliquots were withdrawn at the indi-
cated times and analyzed by SDS-PAGE and autoradiography. To quantify the
rates of phosphorylation, densitometry was carried out on a Bio-Rad GS-710
imaging densitometer with QuantityOne software. Rates are presented on
the right.
FIGURE 3. Phosphorylation of Cas multisite mutants. A, in vitro reactions
were carried out using Cas proteins and 100 M unlabeled ATP for 20 min in
the presence or absence of v-Src. The reactions were analyzed by SDS-PAGE
and silver staining. B, time courses for Cas phosphorylation were carried out
using methods similar to those described in A. Aliquots were withdrawn at
the indicated times and analyzed by SDS-PAGE and silver staining.
FIGURE 4. Kinetics of wild-type Cas phosphorylation at different sub-
strate concentrations. A, WT Cas was incubated in the presence of 50 nM
v-Src at 30 °C in kinase assay buffer. Reactions were started by the addition of
100 M unlabeled ATP plus [-32P]ATP (5 Ci). Aliquots were withdrawn at the
indicated times and analyzed by 8% SDS-PAGE and autoradiography. B, incor-
poration of 32P into Cas was measured by exposing the dried gels to a Phos-
phorImager screen (GE Healthcare) and quantifying the band intensity using
ImageQuant software. A graph of velocity (PhosphorImager units/min) versus
substrate concentration is shown. The data were fit to the Michaelis-Menten
equation using nonlinear regression analysis.
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phorImager screen (GEHealthcare). As we reported previously
(14), higher concentrations ofWTCas result in increased accu-
mulation of phosphorylated Cas, consistent with a processive
mechanism (Fig. 4). To ensure that the reaction had gone to
completion, we carried out stoichiometry measurements using
1MCas. 32P-LabeledCaswas excised from the gel, solubilized,
and analyzed in a liquid scintillation counter. These experi-
ments gave a stoichiometry of 15.1 1.9mol of phosphate/mol
of protein for wild-type Cas, indicating that most of the 17 sites
were phosphorylated in this experiment. We also observed an
increase in the accumulation of phosphorylated CasF7 and
CasF12 with increasing substrate concentrations (Fig. 5). Stoi-
chiometry measurements for CasF7 and CasF12 were 6.1  1.9
and 4.7  0.9 mol of phosphate/mol of protein, respectively.
The dependence of product formation on Cas concentration in
these experiments suggests that the multisite mutants CasF7
and CasF12 are phosphorylated processively by Src.
We carried out similar experiments with varying concen-
trations of Src. Because the enzyme and substrate remain bound
during the multiple phosphorylation
events inaprocessivemechanism, the
rate of progression from an interme-
diatephosphorylated formto the fully
phosphorylated product is independ-
ent of the enzyme concentration. In
contrast, for a nonprocessive mecha-
nism in which each phosphorylation
depends on enzyme-substrate bind-
ing, the rate of progression depends
on enzyme concentration. We per-
formed pulse-chase assays in which
the chase reactions contained dif-
ferent concentrations of Src. We
first incubated Src (800 nM) andWT
Cas, CasF7, or CasF12 (2M)with 0.1
M [-32P]ATP for 3 min (pulse)
and then diluted the reaction to
yield final Src concentrations rang-
ing from 100 to 600 nM. The dilu-
tions contained an excess of unla-
beled ATP (0.5 mM final) to reduce
the specific activity of [-32P]ATP
to levels that were undetectable in
our assay. Our results showed com-
parable shifts in electrophoretic
mobility at different concentrations
of Src forWTCas, CasF7, andCasF12
(Fig. 6). Time courses at 100 and 600
nMSrc showed similar rates of phos-
phorylation (Fig. 6). This lack of
dependence on Src concentration
was consistent with a processive
mechanism. In addition, phospho-
rylated Cas migrated as a single
band in each case. Nonprocessive
phosphorylation produces diffuse
bands because of the formation of
partially phosphorylated products,
which migrate at various molecular weights (14). Our results
suggest that even in the case of a mutant lacking 12 phospho-
rylation sites (CasF12), Src bound Cas once and completely
phosphorylated the remaining sites before dissociating.
Add-back Mutants of Cas Are Phosphorylated—To test
whether a threshold number of tyrosines are required for Src to
phosphorylate the substrate domain of Cas, we generated two
“add-back” mutants. As noted above, the YXXP motifs in the
substrate domain of Cas can be divided into YDXP and YQXP
motifs. Our previous synthetic peptide data show that a sub-
strate with the Tyr253 sequence has the highest value of kcat/Km
for Src phosphorylation among the YDXP motifs, whereas a
Tyr196 peptide has the highest kcat/Km among the YQXPmotifs
(9). We also reported that Tyr253 plays a critical role in the
migration of Src transformed cells (9). Therefore, we reintro-
duced Tyr253 alone or together with Tyr196 into CasF17 to gen-
erate the CasF17-Tyr253 and CasF17-Tyr253/Tyr196 mutants. We
carried out in vitro kinase assays using purified Src, Cas (WT
andmutants), and [-32P]ATP. The results show that Src is able
FIGURE 5. Kinetics of mutant Cas phosphorylation at different substrate concentrations. A, CasF7 was
incubated in the presence of 50 nM v-Src at 30 °C in kinase assay buffer. Reactions were started by the addition
of 100 M unlabeled ATP plus [-32P]ATP (5 Ci). Aliquots were withdrawn at the indicated times and analyzed
by 8% SDS-PAGE and autoradiography. B, incorporation of 32P into Cas was measured by exposing the dried
gels to a PhosphorImager screen and quantifying the band intensity using ImageQuant software. A graph of
velocity (PhosphorImager units/min) versus substrate concentration is shown. The data were fit to the Michae-
lis-Menten equation using nonlinear regression analysis. C, CasF12 phosphorylation reactions were ana-
lyzed by SDS-PAGE as described above in A. D, CasF12 phosphorylation was quantified by PhosphorImager
as shown in B.
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to phosphorylate the add-back mutants (Fig. 7). The phospho-
rylation levels are clearly lower than forWTCas, and there is no
shift in electrophoretic mobility for the mutants. Nonetheless,
the results show that Src can gain access to individual tyrosines
in themiddle of the substrate region of Cas, even in the absence
of surrounding sites.
Cas Phosphorylation Sites Are Dispensable for Src-mediated
Anchorage-independent Growth—We tested the ability of wild-
type and mutant forms of Cas to promote growth of fibroblasts
derived from Cas-deficient mice. We produced cell lines stably
expressing wild-type Cas and the following Cas mutants in the
presence or absence of v-Src: CasF7, CasF12, CasF17, and CasF17-
Tyr253 (Fig. 8). For comparison, we included a single-site mutant
(Cas Y253F) in our study. As we observed previously (9), Cas did
not affect the anchored growth rates of Src-transformed or -non-
transformed cells (data not shown). Anchorage-independent
growth is a reliable hallmark of most tumor cells (22, 23). As
reported previously (4, 7, 9), the ability of Src to promote anchor-
age-independent growth was augmented by Cas (Fig. 9A). Cells
transfected with control vectors or with wild-type Cas alone did
not grow in suspension, whereas cells expressing Src alone dou-
bled in number in 11 days (Fig. 9A). In contrast, Src transfectants
expressingeitherwild-typeCasorY253FCas increased theirnum-
bers by over 7- or 14-fold, respectively, in the same time period
(Fig. 9A). This level of anchorage-independent growth was signif-
icantly higher than for the cells transfected with Src alone (p 
0.0001). Src transfectants expressing mutant forms of Cas (CasF7,
CasF12, CasF17, or the add-back mutant CasF17-Tyr253) grew at
least aswell as cells expressingwild-typeCas (Fig. 9,A andB). This
anchorage-independent growth of Src transfectants expressing
mutant forms of Cas lacking multiple phosphorylation sites (in
particular, CasF17) suggests that Cas augments the ability of Src to
override anchorage dependence, even in the absence of substrate
domain phosphorylation.
Cas Phosphorylation Sites Are Necessary for Src to Promote
Cell Migration—Data described above indicate that Src-medi-
ated phosphorylation of Cas is not necessary to promote non-
anchored growth. On the other hand, phosphorylation of Cas
by Src has been shown to play a critical role in cell migration
FIGURE 6. Phosphorylation of WT and mutant forms of Cas at different Src
concentrations. A, left, pulse-chase experiments were carried out on WT Cas at
different Src concentrations. In the pulse reaction, Cas and Src were incubated on
ice in the presence of 0.1 M [-32P]ATP. After 3 min, aliquots were removed from
the reaction and diluted into four separate tubes containing kinase assay buffer
and excess unlabeled ATP (0.5 mM final) to give final Src concentrations of 100,
200, 400, and 600 nM. The chase reaction was carried out at 30 °C for 25 min.
Reactions were stopped by adding SDS-PAGE sample buffer and boiling. Equal
amounts of Cas from each reaction were analyzed by SDS-PAGE and autoradiog-
raphy. Aliquots removed after 3-min pulse reaction were also analyzed on the
gels. Right, in separate pulse-chase reactions, time courses were followed at Src
concentrations of 100 and 600 nM. B, similar experiments were performed for
CasF7. C, similar experiments were performed for CasF12.
FIGURE 7. Add-back mutants of Cas are phosphorylated by Src. In vitro
kinase assays were carried out at 30 °C using Cas proteins (WT or add-back
mutants), v-Src, and [-32P]ATP. Aliquots were withdrawn at the indicated
times and analyzed by SDS-PAGE and autoradiography. A, phosphorylation of
add-back mutant CasF17  Tyr253. B, phosphorylation of add-back mutant
CasF17  Tyr253/Tyr196.
FIGURE 8. Expression of WT and mutant Cas in Cas/ fibroblasts. Cas-
deficient fibroblasts were transfected with wild-type or mutant forms of Cas
(in pBABEhygro) and v-Src (in pBABEpuro) and selected for hygromycin and
puromycin resistance. Cells marked minus were transfected with the appro-
priate vector controls. Cells were lysed in modified radioimmune precipita-
tion assay buffer, and lysates (30 g) were analyzed by immunoblotting using
Cas, v-Src, or -actin antibodies. A, Cas Y253F, CasF17, and CasF17  Tyr253
mutants. B, CasF7 and CasF12 mutants.
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(8–10, 16, 24). To test whether the Cas mutants are able to pro-
mote cell migration, we examined the ability of Cas-deficient cells
expressingCas and/or Src tomigrate throughpores in amigration
chamber. As shown in Fig. 9C, there was a significant increase in
migration for cells expressing wild-type Cas together with Src
as comparedwith cells expressing Src orCas alone (p 0.0002).
Cells expressing Src together with CasF7, CasF12, or CasF17
showed levels of migration that were comparable with vector
controls (Fig. 9D). We confirmed our results using 8 M mem-
branes employed by Honda et al. (7) (Fig. 9E).
We foundpreviously thatTyr253 in the substrate domain ofCas
significantly increases migration of Src-transformed cells (9). To
test whether Tyr253 alone is sufficient to promote cell migration,
we carried outmigration assays for cells transfected with the add-
back mutant CasF17-Tyr253. Fewer than 0.5% of these cells
migrated, indicating that Tyr253 is not sufficient to promote cell
migration (Fig. 9C). Inagreementwithprevious reports (8, 10), our
results show thatphosphorylationofmultiple sites in the substrate
domain of Cas is required for cell migration.
DISCUSSION
Cas is representative of a class of
efficient Src substrates that contain
SH3 and SH2 ligands and are phos-
phorylated on multiple sites. Multi-
site phosphorylation of Cas is
important for the various physio-
logical roles of Cas in normal and
transformed cells (5, 7, 8, 10, 16, 18).
Several lines of evidence indicate
that Src is directly responsible for
phosphorylating Cas (3, 25, 26).
Here, we have investigated the
mechanism bywhich Src recognizes
Cas phosphorylation sites. Our pre-
vious results show that (at least in
vitro) Src phosphorylates Cas by a
processive mechanism (14). The
biological importance of processive
phosphorylation is not clear at pres-
ent. In the case of the Cdk inhibitor
Sic1, phosphorylation occurs by a
nonprocessive mechanism. The
necessity for multisite, nonproces-
sive phosphorylation introduces a
highly cooperative step and creates
a switch-like response (15). The
processive phosphorylation of Cas
(and lack of dependence on enzyme
concentration) suggests that Cas
phosphorylation is unlikely to dis-
play a switch-like response. Instead,
the biological importance of proces-
sive phosphorylation may be to
greatly increase the rate of multisite
phosphorylation, enabling faster
assembly of the Cas-SH2 docking
interactions and a faster response
time. In a distributive mechanism,
partially phosphorylated intermediates of Cas would act effec-
tively as competitive inhibitors. Src would need to phosphoryl-
ate a significant portion of the entire pool of Cas molecules to
produce highly phosphorylated Cas and achieve a biological
effect. Thus, the processive mechanism allows for a more
potent effect of Src than would be realized by a distributive
mechanism.
One question investigated in this study is whether phospho-
rylation of the sites within the Cas substrate domain follows a
defined sequence. Several examples are known in which phos-
phorylation at one site on a protein “primes” another site for
subsequent phosphorylation. As an initial test of this possibil-
ity, we generated four single-site mutants of Cas in which the
most favored Src phosphorylation sites (as defined by synthetic
peptide substrates) were altered. Our results show that these
mutants are phosphorylated processively by Src (Fig. 2 and data
not shown). Thus, of the sites tested, no single site acted as a
FIGURE 9. Effects of Src and Cas on Src-mediated anchorage-independent growth and migration. A and B,
anchorage-independent growth. 20,000 cells were plated in 12-well tissue culture plates. Cell numbers were
obtained using a Coulter counter after 11 days. Open bars, cells without Src; closed bars, cells expressing Src. C
and D, cell migration assays. 200,000 cells were plated on cell culture inserts (3-m pore size) in 6-well plates.
Cell migration was measured after 72 h as the percent of cells found in the bottom well/total cell number. E, cell
migration assays were carried out using 8-m pore size membranes, and cell migration was examined after
24 h.
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“linchpin” that permitted phosphorylation of subsequent sites,
suggesting that Cas phosphorylation by Src does not follow an
obligatory sequence.
The lack of a specific sequence of phosphorylations was rein-
forced by experiments on the multisite mutants CasF7 and
CasF12. These mutants, which lack the “best” phosphorylation
sites, were phosphorylated processively (Figs. 3 and 5). Presum-
ably, if there were an obligatory order of phosphorylation, these
mutants would not have been phosphorylated at multiple sites.
The data suggest that tyrosines in the Cas substrate domain are
not kinetically distinguishable and that any group of tyrosines
present in the substrate regionwould be sufficient for Src phos-
phorylation. Furthermore, Src phosphorylatedmutant forms of
Cas in which all but one or two sites had been eliminated
(CasF17-Tyr253 and CasF17-Tyr253/Tyr196; Fig. 7). It is notewor-
thy that these sites (Tyr196 and Tyr253) were distant in primary
sequence from the C-terminal Src-binding site of Cas. These
data stand in contrast to our previous results using a simple
synthetic peptide model of Cas. The peptide contained two
YDXP motifs from Cas (modeled on the sequence of Tyr253)
and a C-terminal Src SH2 binding sequence. The Src family
kinase Hck phosphorylates the sites in a defined order, pro-
ceeding fromC terminus toN terminus (27). Presumably, in the
intact Cas protein, a large number of potential phosphorylation
sites are available to Src. The structure of the Cas substrate
domain appears to be flexible enough so that Src (which is pre-
sumably bound at the C terminus) can gain access to sites far
from the C-terminal region, in the middle of Cas.
Our data also address the biological importance of the Cas
phosphorylation sites. We reintroduced wild-type or mutant
forms of Cas into fibroblasts derived from Cas knock-out cells,
in the presence or absence of Src. In agreement with others (4,
7, 8) and with our previous results (9), we found that the ability
of Src to promote anchorage-independent growth is aug-
mented by Cas (Fig. 9A). In contrast to these results, Brabek
et al. (17) recently reported that Cas does not alter the anchor-
age-independent growth characteristics of Src-transformed
cells. (Brabek et al. (17) did note an increase in the number of
colonies formed in soft agar for cells expressing Cas and Src
together, but the increase is not statistically significant.) The
reason for this discrepancy is not clear at present; one possibil-
ity is that the expression levels of Src and Cas differ among the
cell lines tested by various investigators. In any case, our data
(Fig. 9A) show that the difference in nonanchored growth
between Cas-deficient and Cas-expressing cells is a matter of
degree rather than an all-or-none phenomenon.
It has been reported previously that Cas variants lacking the
SH3 domain or the YDXP sites from the substrate domain can
promote anchorage-independent growth of Src-transformed
cells (8). Here, we show that Cas mutants lacking the major
phosphorylation sites (CasF7 andCasF12) or even all of the phos-
phorylation sites (CasF17) can promote anchorage-independent
growth of the Cas knock-out cells in the presence of Src. Thus,
Cas has the capacity to promote anchorage-independent
growth in the absence of phosphorylation. Thismay be because
of a scaffolding function of Cas in which Cas (via its C-terminal
region containing SH3 and SH2 ligands) recruits Src to phos-
phorylate focal adhesion kinase, paxillin, and other integrin-
associated substrates (17). Cas lacking a substrate domain has
been shown to act as a dominant-negative mutant in COS-7
cells, consistent with its ability to bind these components but
not downstream effectors (28). An additional mechanism may
involve the ability of the C-terminal polyproline region of Cas
to bind to the SH3 domain, relieving Src autoinhibition and
enhancing kinase activity (5, 29).
Phosphorylation of the YXXP motifs in the Cas substrate
domain has been shown previously to be necessary for cell
migration (8, 17, 18). Within these motifs, the YDXP
sequences are shown to be of particular importance, as a Cas
construct lacking the YDXP motifs is deficient in cell migra-
tion and actin stress fiber organization (8). In wound healing
assays, a Cas mutant possessing as few as 6 tyrosines gives
some activity (10), indicating that the full complement of
sites is not required. Here, in our study, we used Cas mutants
lacking multiple phosphorylation motifs (CasF7, CasF12, and
CasF17) to determine whether there were a threshold number
of tyrosine motifs for cell migration. As shown previously
(18), CasF17 is incapable of supporting cell migration in Src-
transformed cells (Fig. 9,C andD). Reintroduction of a single
site (Tyr253) that was shown previously to be important in
cell migration did not rescue this defect (Fig. 9C). Further-
more, the CasF7 and CasF12 variants did not promote migra-
tion (Fig. 9D) despite the fact that these mutants were phos-
phorylated processively (Figs. 3 and 5). Thus, it is clear that
multisite phosphorylation of Cas, although necessary for cell
migration activity, is not sufficient. In contrast, multisite
phosphorylation is dispensable for anchorage-independent
growth in Src-transformed cells.
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